Table 3 Univariate and Multivariate analysis of preoperative variables predicting one-year mortality

Body mass index > 27

0.297

0.039 (0.000–17.449)

Age > 60 years

0.133

0.453 (0.161–1.272)

Sex

0.257

0.037 (0.000–11.176)

Hepatitis B

0.671

0.803 (0.291–2.213)

Hepatitis C

0.584

0.568 (0.075–4.317)

Hemoglobin < 10g/dL

0.402

2.380 (0.313–18.110)

Platelet < 150 × 10⁹/L

0.986

0.989 (0.279–3.504)

Albumin < 35 g/L

0.064

2.656 (0.945–7.466)

0.453

0.549 (0.114–2.633)

Prognostic nutritional index < 45

0.021

3.545 (1.211–10.375)

0.103

2.974 (0.802–11.030)

Platelet/lymphocyte ratio ≥ 150

0.089

2.412 (0.875–6.652)

0.189

2.112 (0.692–6.447)

Neutrophil/lymphocyte ratio ≥ 5

0.038

3.368 (1.072–10.585)

0.839

0.855 (0.188–3.881)

Alpha-fetoprotein ≥ 1000 ng/mL

0.244

1.973 (0.628–6.198)

Tumor (≥ 10 cm)

0.469

1.526 (0.486–4.794)

Tumor (≥ 5 cm)

0.147

2.149 (0.765–6.037)

Bilirubin > 31 μmol/L

0.531

0.046 (0.000–710.247)

Child-Pugh B/C

0.004

4.941 (1.685–14.491)

0.035

5.479 (1.130–26.551)

American Society of Anesthesiology score (ASA) > 2

0.319

1.727 (0.590–5.052)

Eastern Cooperative Oncology Group (ECOG) > 1

0.726

1.437 (0.189–10.930)

Tumors (≥ 2)

0.001

5.897 (2.105–17.262)

0.001

7.105 (2.305–21.899)